Chlamydia trachomatis ompA variants in trachoma: What do they tell us?

PLoS Neglected Tropical Diseases

Volumn 2, Issue 9, 2008, Pages

  Andreasen, Aura A ^a   Burton, Matthew J ^a,b   Holland, Martin J ^a,b   Polley, Spencer ^a   Faal, Nkoyo ^b   Mabey, David C W ^a   Bailey, Robin L ^a,b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; OUTER MEMBRANE PROTEIN A; TETRACYCLINE; ANTIINFECTIVE AGENT; OMPA OUTER MEMBRANE PROTEINS; OUTER MEMBRANE PROTEIN;

ADULT; ARTICLE; BACTERIAL STRAIN; CHILD; CHLAMYDIA TRACHOMATIS; EYE INFECTION; FOLLOW UP; GAMBIA; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; NONHUMAN; NOSE INFECTION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SINGLE DRUG DOSE; TRACHOMA; CONJUNCTIVITIS; DISEASE TRANSMISSION; GENETIC VARIABILITY; GENETICS; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BACTERIAL OUTER MEMBRANE PROTEINS; BASE SEQUENCE; CHLAMYDIA TRACHOMATIS; CONJUNCTIVITIS, INCLUSION; GENETIC VARIATION; GENOTYPE; HUMANS; POLYMERASE CHAIN REACTION; TRACHOMA;

EID: 56149102503     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000306     Document Type: Article

References (28)

1. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, et al. (2004) Global data on visual impairment in the year 2002. Bull World Health Organ 82(11): 844-51.
2. Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY (1995) Global data on blindness. Bull World Health Organ 73(1): 115-21.
3. Global Elimination of Blinding Trachoma (1998) Resolution WHA 51.11 Adopted by the World Health Assembly 16 May 1998, World Health Organization.
4. Caldwell HD, Perry LJ (1982) Neutralization of Chlamydia trachomatis infectivity with antibodies to the major outer membrane protein. Infect Immun 38(2): 745-54.
5. Brunelle BW, Nicholson TL, Stephens RS (2004) Microarray-based genomic surveying of gene polymorphisms in Chlamydia trachomatis. Genome Biol 5(6): R42.
6. Carlson JH, Porcella SF, McClarty G, Caldwell HD (2005) Comparative genomic analysis of Chlamydia trachomatis oculotropic and genitotropic strains. Infect Immun 73(10): 6407-18.
7. Bain DL, Lietman T, Rasmussen S, Kalman S, Fan J, et al. (2001) Chlamydial genovar distribution after communitywide antibiotic treatment. J Infect Dis 184(12): 1581-8.
8. Dean D, Schachter J, Dawson CR, Stephens RS (1992) Comparison of the major outer membrane protein variant sequence regions of B/Ba isolates: a molecular epidemiologic approach to Chlamydia trachomatis infections. J Infect Dis 166(2): 383-92.
9. Hayes LJ, Bailey RL, Mabey DC, Clarke IN, Pickett MA, et al. (1992) Genotyping of Chlamydia trachomatis from a trachoma-endemic village in the Gambia by a nested polymerase chain reaction: identification of strain variants. J Infect Dis 166(5): 1173-7.
10. Hayes LJ, Pecharatana S, Bailey RL, Hampton TJ, Pickett MA, et al. (1995) Extent and kinetics of genetic change in the omp1 gene of Chlamydia trachomatis in two villages with endemic trachoma. J Infect Dis 172(1): 268-72.
11. Hsieh YH, Bobo LD, Quinn TC, West SK (2001) Determinants of trachoma endemicity using Chlamydia trachomatis ompA DNA sequencing. Microbes Infect 3(6): 447-58.
12. Smith A, Munoz B, Hsieh YH, Bobo L, Mkocha H, et al.(2001) OmpA genotypic evidence for persistent ocular Chlamydia trachomatis infection in Tanzanian village women. Ophthalmic Epidemiol 8(2-3): 127-35.
13. Takourt B, de Barbeyrac B, Khyatti M, et al. Direct genotyping and nucleotide sequence analysis of VS1 and VS2 of the Omp1 gene of Chlamydia trachomatis from Moroccan trachomatous specimens. Microbes Infect 3(6): 459-66.
14. Zhang J, Lietman T, Olinger L, Miao Y, Stephens RS (2004) Genetic diversity of Chlamydia trachomatis and the prevalence of trachoma. Pediatr Infect Dis J 23(3): 217-20.
15. Geisler WM, Suchland RJ, Whittington WL, Stamm WE (2003) The relationship of serovar to clinical manifestations of urogenital Chlamydia trachomatis infection. Sex Transm Dis 30(2): 160-5.
16. Burton MJ, Holland MJ, Faal N, Aryee EA, Alexander ND, et al. (2003) Which Members of a Community Need Antibiotics to Control Trachoma? Conjunctival Chlamydia trachomatis Infection Load in Gambian Villages. Invest Ophthalmol Vis Sci 44(10): 4215-22.
17. Burton MJ, Holland MJ, Makalo P, Aryee EA, Alexander ND, et al. (2005) Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study. Lancet 365(9467): 1321-8.
18. Burton MJ, Bailey RL, Jeffries D, Mabey DC, Holland MJ (2004) Cytokine and fibrogenic gene expression in the conjunctivas of subjects from a Gambian community where trachoma is endemic. Infect Immun 72(12): 7352-6.
19. Dawson CR, Jones BR, Tarizzo ML (1981) Guide to Trachoma Control. Geneva: World Health Organization.
20. Solomon AW, Holland MJ, Burton MJ, West SK, Alexander ND, et al. (2003) Strategies for control of trachoma: observational study with quantitative PCR. Lancet 362(9379): 198-204.
21. Tajima F (1989) Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123(3): 585-95.
22. Rozas J, Sanchez-DelBarrio JC, Messeguer X, Rozas R (2003) DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics 19(18): 2496-7.
23. Fu YX, Li WH (1993) Statistical tests of neutrality of mutations. Genetics 133(3): 693-709.
24. Millman K, Black CM, Stamm WE, Jones RB, Hook EW 3rd, et al. (2006) Population-based genetic epidemiologic analysis of Chlamydia trachomatis serotypes and lack of association between ompA polymorphisms and clinical phenotypes. Microbes Infect 8(3): 604-11.
25. Hanisch FG (2005) Design of a MUC1-based cancer vaccine. Biochem Soc Trans 33(Pt 4): 705-8.
26. Chapman HA (2006) Endosomal proteases in antigen presentation. Curr Opin Immunol 18(1): 78-84.
27. Kari L, Whitmire W, Karlson J, Crane DD, Reveneau N, et al. (2008) Pathogenic diversity among Chlamydia trachomatis ocular strains in non-human primates is affected by subtle genomic variations J Infect Dis 197(3): 449-56.
28. West S, Munoz B, Bobo L, Quinn TC, Mkocha H, et al. (1993) Nonocular Chlamydia infection and risk of ocular reinfection after mass treatment in a trachoma hyperendemic area. Invest Ophthalmol Vis Sci 34(11): 3194-8.